Literature DB >> 19596190

Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.

Patrick Hundsdoerfer1, Marion Albrecht, Ursula Rühl, Rüdiger Fengler, Andreas E Kulozik, Günter Henze.   

Abstract

BACKGROUND: Current standard therapy for high-grade osteosarcoma is neoadjuvant chemotherapy and complete resection of the primary tumour. Irradiation can improve local control if complete tumour resection is not possible or refused, but data on long-term outcome are not available. PATIENTS AND METHODS: We report on long-term results for overall survival, occurrence of local recurrence and metastasis, joint function and side-effects in 13 patients with high-grade osteosarcoma having been treated with a combination of local irradiation and polychemotherapy (median follow-up of 13.5 years).
RESULTS: Ten of the 13 patients were alive 4-23 years after diagnosis. Three patients suffered local recurrence, in 2 of them tumour control and long-term survival could be achieved by secondary salvage surgery and polychemotherapy. In 5 patients pathological fractures of the irradiated bones occurred, none of them was associated with local recurrence. In 7 of the 10 long-term survivors good or fair joint function was achieved.
CONCLUSIONS: We conclude that combination of chemotherapy and intensive local irradiation can achieve long-term local control and even cure in high-grade osteosarcoma. Thus radiation therapy may represent an alternative to definite surgery in selected patients, in particular in those with good response to chemotherapy, when surgery is not feasible or refused.

Entities:  

Mesh:

Year:  2009        PMID: 19596190     DOI: 10.1016/j.ejca.2009.06.006

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

1.  Salivary gland second cancer after bone sarcoma treatment.

Authors:  Alessandra Longhi; Costantino Errani; Marco Gambarotti; Christina Ferrari; Jennifer Kreshak; Georgios N Panagopoulos; Andreas F Mavrogenis; Davide Donati
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-07-15

2.  Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model.

Authors:  C Blattmann; M Thiemann; A Stenzinger; A Christmann; E Roth; V Ehemann; J Debus; A E Kulozik; W Weichert; P E Huber; S Oertel; A Abdollahi
Journal:  Strahlenther Onkol       Date:  2013-06-27       Impact factor: 3.621

3.  Carbon-ion radiotherapy of spinal osteosarcoma with long-term follow.

Authors:  Wei Zhang; Masato Tanaka; Yoshihisa Sugimoto; Tomoyuki Takigawa; Toshifumi Ozaki
Journal:  Eur Spine J       Date:  2015-08-23       Impact factor: 3.134

4.  Palliative embolisation for advanced bone sarcomas.

Authors:  A F Mavrogenis; G Rossi; G Altimari; T Calabrò; A Angelini; E Palmerini; E Rimondi; P Ruggieri
Journal:  Radiol Med       Date:  2012-08-09       Impact factor: 3.469

5.  Chemoradiotherapy in the treatment of inoperable high-grade osteosarcoma.

Authors:  Micaela M Hernberg; Aarne H Kivioja; Tom O Böhling; Rita J Janes; Tom A Wiklund
Journal:  Med Oncol       Date:  2010-06-17       Impact factor: 3.064

6.  CRIF1 as a potential target to improve the radiosensitivity of osteosarcoma.

Authors:  Qian Ran; Feng Jin; Yang Xiang; Lixin Xiang; Qiushi Wang; Fengjie Li; Li Chen; Yuan Zhang; Chun Wu; Luping Zhou; Yanni Xiao; Lili Chen; Jiang Wu; Jiang F Zhong; Shengwen Calvin Li; Zhongjun Li
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

7.  WEE1 inhibition sensitizes osteosarcoma to radiotherapy.

Authors:  Jantine PosthumaDeBoer; Thomas Würdinger; Harm C A Graat; Victor W van Beusechem; Marco N Helder; Barend J van Royen; Gertjan J L Kaspers
Journal:  BMC Cancer       Date:  2011-04-29       Impact factor: 4.430

8.  Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.

Authors:  Claudia Blattmann; Susanne Oertel; Markus Thiemann; Anne Dittmar; Eva Roth; Andreas E Kulozik; Volker Ehemann; Wilko Weichert; Peter E Huber; Albrecht Stenzinger; Jürgen Debus
Journal:  Radiat Oncol       Date:  2015-07-16       Impact factor: 3.481

9.  Is There an Association Between Bone Microarchitecture and Fracture in Patients who were Treated for High-grade Osteosarcoma? A Controlled Study at Long-term Follow-up Using High-resolution Peripheral Quantitative CT.

Authors:  Gerold Holzer; Gerhard Hobusch; Stinus Hansen; Lukas Fischer; Janina M Patsch
Journal:  Clin Orthop Relat Res       Date:  2021-11-01       Impact factor: 4.755

10.  Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-Trans Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor α Expression in Osteosarcoma Cell Lines.

Authors:  Silvia Paukovcekova; Dalibor Valik; Jaroslav Sterba; Renata Veselska
Journal:  Int J Mol Sci       Date:  2020-09-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.